ESC 365 - Ischemic versus dilated cardiomyopathy - differences in clinical characteristics and prognosis depending on heart failure etiology.

ESC Premium Access

Ischemic versus dilated cardiomyopathy - differences in clinical characteristics and prognosis depending on heart failure etiology.

Session: Comorbidities in heart failure

Topic: Prognosis

Speaker: Doctor A. Tyminska (Warsaw, PL)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Agata Tyminska

Medical University of Warsaw, Warsaw (Poland)

0 follower

5 more presentations in this session

Atrial fibrillation or rapid ventricular response in patients with left ventricular dysfunction: which is relevant to the long-term clinical outcome?

Speaker: Doctor G. Benfari (Verona, IT)

HYCHeF: a risk score to predict congestive heart failure incidence in hypertension. (based on 18795 individual patient data)

Speaker: Doctor H. Le (Lyon, FR)

Intravenous iron therapy in acute decompensated heart failure patients with iron deficiency anaemia

Speaker: Doctor A. Kamal (Cairo, EG)

Lectin-like oxidized LDL receptor-1 (LOX-1) in cardiomyocytes (CMs) is involved in the pathogenesis of doxorubicin (DOX)-induced cardiomyopathy

Speaker: Doctor T. Aoyama (Minokamo, JP)

Elevated potassium levels in patients with congestive heart failure: incidence and clinical outcomes. A Danish population based cohort study

Speaker: Doctor R. Thomsen (Aarhus, DK)

Access the full session

Comorbidities in heart failure

Speakers: Doctor A. Tyminska, Doctor G. Benfari, Doctor H. Le, Doctor A. Kamal, Doctor T. Aoyama...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources